|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crinò L, Weder W, van Meerbeeck J and
Felip E; ESMO Guidelines Working Group. Early stage and locally
advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21(Suppl 5): V103–V115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sekhon HS, London CA, Sekhon M, Iversen PL
and Devi GR: c-MYC antisense phosphosphorodiamidate morpholino
oligomer inhibits lung metastasis in a murine tumor model. Lung
Cancer. 60:347–354. 2008. View Article : Google Scholar
|
|
5
|
Fork MA, Murua Escobar H, Soller JT,
Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N,
Hedrich HJ, Bullerdiek J, et al: Establishing an in vivo model of
canine prostate carcinoma using the new cell line CT1258. BMC
Cancer. 8:2402008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Capellá G, Farré L, Villanueva A, Reyes G,
García C, Tarafa G and Lluís F: Orthotopic models of human
pancreatic cancer. Ann NY Acad Sci. 880:103–109. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talmadge JE, Singh RK, Fidler IJ and Raz
A: Murine models to evaluate novel and conventional therapeutic
strategies for cancer. Am J Pathol. 170:793–804. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massagué J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Daniel VC, Marchionni L, Hierman JS,
Rhodes JT, Devereux WL, Rudin CM, Yung R, Parmigiani G, Dorsch M,
Peacock CD, et al: A primary xenograft model of small-cell lung
cancer reveals irreversible changes in gene expression imposed by
culture in vitro. Cancer Res. 69:3364–3373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Frese KK and Tuveson DA: Maximizing mouse
cancer models. Nat Rev Cancer. 7:645–658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Voskoglou-Nomikos T, Pater JL and Seymour
L: Clinical predictive value of the in vitro cell line, human
xenograft, and mouse allograft preclinical cancer models. Clin
Cancer Res. 9:4227–4239. 2003.PubMed/NCBI
|
|
12
|
Hammer S, Sommer A, Fichtner I, Becker M,
Rolff J, Merk J, Klar U and Hoffmann J: Comparative profiling of
the novel epothilone, sagopilone, in xenografts derived from
primary non-small cell lung cancer. Clin Cancer Res. 16:1452–1465.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masui O, White NM, DeSouza LV, Krakovska
O, Matta A, Metias S, Khalil B, Romaschin AD, Honey RJ, Stewart R,
et al: Quantitative proteomic analysis in metastatic renal cell
carcinoma reveals a unique set of proteins with potential
prognostic significance. Mol Cell Proteomics. 12:132–144. 2013.
View Article : Google Scholar :
|
|
14
|
Hou Q, Tan HT, Lim KH, Lim TK, Khoo A, Tan
IB, Yeoh KG and Chung MC: Identification and functional validation
of caldesmon as a potential gastric cancer metastasis-associated
protein. J Proteome Res. 12:980–990. 2013. View Article : Google Scholar
|
|
15
|
Qin X, Chen Q, Sun C, Wang C, Peng Q, Xie
L, Liu Y and Li S: High-throughput screening of tumor
metastatic-related differential glycoprotein in hepatocellular
carcinoma by iTRAQ combines lectin-related techniques. Med Oncol.
30:4202013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu T, Li J, Yan M, Liu L, Lin H, Zhao F,
Sun L, Zhang Y, Cui Y, Zhang F, et al: MicroRNA-193a-3p and -5p
suppress the metastasis of human non-small-cell lung cancer by
downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway.
Oncogene. 34:413–423. 2015. View Article : Google Scholar
|
|
17
|
Lin HC, Zhang FL, Geng Q, Yu T, Cui YQ,
Liu XH, Li J, Yan MX, Liu L, He XH, et al: Quantitative proteomic
analysis identifies CPNE3 as a novel metastasis-promoting gene in
NSCLC. J Proteome Res. 12:3423–3433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dunkley PR, Jarvie PE and Robinson PJ: A
rapid Percoll gradient procedure for preparation of synaptosomes.
Nat Protoc. 3:1718–1728. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao Q, Feng Y, Jia X, Yin L, Zheng Y,
Ouyang D, Zhou H and Zhang L: Proteome analysis of hepatic
non-parenchymal cells of immune liver fibrosis rats. Sci China Life
Sci. 57:303–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bartnitzke S, Motzko H, Caselitz J,
Kornberg M, Bullerdiek J and Schloot W: A recurrent marker
chromosome involving chromosome 1 in two mammary tumors of the dog.
Cytogenet Cell Genet. 60:135–137. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chambers JK, Uchida K, Ise K and Nakayama
H: Cystic rete ovarii and uterine tube adenoma in a rabbit. J Vet
Med Sci. 76:909–912. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cousins FL, Murray A, Esnal A, Gibson DA,
Critchley HO and Saunders PT: Evidence from a mouse model that
epithelial cell migration and mesenchymal-epithelial transition
contribute to rapid restoration of uterine tissue integrity during
menstruation. PLoS One. 9:e863782014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kamalidehghan B, Houshmand M,
Kamalidehghan F, Jafarzadeh N, Azari S, Akmal SN and Rosli R:
Establishment and characterization of two human breast carcinoma
cell lines by spontaneous immortalization: Discordance between
estrogen, progesterone and HER2/neu receptors of breast carcinoma
tissues with derived cell lines. Cancer Cell Int. 12:432012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sozo F, Wallace MJ, Hanna MR, Flecknoe SJ,
Cock ML, Maritz GS, Harding R and Hooper SB: Alveolar epithelial
cell differentiation and surfactant protein expression after mild
preterm birth in sheep. Pediatr Res. 59:151–156. 2006. View Article : Google Scholar
|
|
25
|
Woodcock-Mitchell J, Mitchell JJ, Reynolds
SE, Leslie KO and Low RB: Alveolar epithelial cell keratin
expression during lung development. Am J Respir Cell Mol Biol.
2:503–514. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ito Y, Ahmad A, Kewley E and Mason RJ:
Hypoxia-inducible factor regulates expression of surfactant protein
in alveolar type II cells in vitro. Am J Respir Cell Mol Biol.
45:938–945. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ito Y and Mason RJ: The effect of
interleukin-13 (IL-13) and interferon-γ (IFN-γ) on expression of
surfactant proteins in adult human alveolar type II cells in vitro.
Respir Res. 11:1572010. View Article : Google Scholar
|
|
28
|
Peng T, Zhang P, Liu J, Nguyen T,
Bolshakov S, Belousov R, Young ED, Wang X, Brewer K, López-Terrada
DH, et al: An experimental model for the study of
well-differentiated and dedifferentiated liposarcoma; deregulation
of targetable tyrosine kinase receptors. Lab Invest. 91:392–403.
2011. View Article : Google Scholar :
|
|
29
|
Lv S, Tang Z, Li M, Lin J, Song W, Liu H,
Huang Y, Zhang Y and Chen X: Co-delivery of doxorubicin and
paclitaxel by PEG-polypeptide nanovehicle for the treatment of
non-small cell lung cancer. Biomaterials. 35:6118–6129. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Munoz R, Man S, Shaked Y, Lee CR, Wong J,
Francia G and Kerbel RS: Highly efficacious nontoxic preclinical
treatment for advanced metastatic breast cancer using combination
oral UFT-cyclophosphamide metronomic chemotherapy. Cancer Res.
66:3386–3391. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia D, Yan M, Wang X, Hao X, Liang L, Liu
L, Kong H, He X, Li J and Yao M: Development of a highly metastatic
model that reveals a crucial role of fibronectin in lung cancer
cell migration and invasion. BMC Cancer. 10:3642010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Caceres G, Zhu XY, Jiao JA, Zankina R,
Aller A and Andreotti P: Imaging of luciferase and GFP-transfected
human tumours in nude mice. Luminescence. 18:218–223. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ciana P, Brena A, Sparaciari P, Bonetti E,
Di Lorenzo D and Maggi A: Estrogenic activities in rodent
estrogen-free diets. Endocrinology. 146:5144–5150. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Takahashi M, Furihata M, Akimitsu N,
Watanabe M, Kaul S, Yumoto N and Okada T: A highly bone marrow
metastatic murine breast cancer model established through in vivo
selection exhibits enhanced anchorage-independent growth and cell
migration mediated by ICAM-1. Clin Exp Metastasis. 25:517–529.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang F, Lin H, Gu A, Li J, Liu L, Yu T,
Cui Y, Deng W, Yan M, Li J, et al: SWATH™- and iTRAQ-based
quantitative proteomic analyses reveal an overexpression and
biological relevance of CD109 in advanced NSCLC. J Proteomics.
102:125–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Conway AE, Lindgren A, Galic Z, Pyle AD,
Wu H, Zack JA, Pelligrini M, Teitell MA and Clark AT: A
self-renewal program controls the expansion of genetically unstable
cancer stem cells in pluripotent stem cell-derived tumors. Stem
Cells. 27:18–28. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mimura T, Ito A, Sakuma T, Ohbayashi C,
Yoshimura M, Tsubota N, Okita Y and Okada M: Novel marker D2-40,
combined with calretinin, CEA, and TTF-1: An optimal set of
immunodiagnostic markers for pleural mesothelioma. Cancer.
109:933–938. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Ordóñez NG: The immunohistochemical
diagnosis of mesothelioma: A comparative study of epithelioid
mesothelioma and lung adenocarcinoma. Am J Surg Pathol.
27:1031–1051. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yokouchi H, Yamazaki K, Asahina H,
Shigemura M, Moriyama T, Takaoka K, Moriya J, Itoh T, Kinoshita I,
Dosaka-Akita H, et al: Establishment and characterization of
amylase-producing lung adenocarcinoma cell line, IMEC-2. Anticancer
Res. 26B:2821–2827. 2006.
|
|
40
|
Moldvay J, Jackel M, Bogos K, Soltész I,
Agócs L, Kovács G and Schaff Z: The role of TTF-1 in
differentiating primary and metastatic lung adenocarcinomas. Pathol
Oncol Res. 10:85–88. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Bejarano PA, Baughman RP, Biddinger PW,
Miller MA, Fenoglio-Preiser C, al-Kafaji B, Di Lauro R and Whitsett
JA: Surfactant proteins and thyroid transcription factor-1 in
pulmonary and breast carcinomas. Mod Pathol. 9:445–452.
1996.PubMed/NCBI
|
|
42
|
Minotti G, Menna P, Salvatorelli E, Cairo
G and Gianni L: Anthracyclines: Molecular advances and
pharmacologic developments in antitumor activity and
cardiotoxicity. Pharmacol Rev. 56:185–229. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Tacar O, Sriamornsak P and Dass CR:
Doxorubicin: An update on anticancer molecular action, toxicity and
novel drug delivery systems. J Pharm Pharmacol. 65:157–170. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Ramalingam SS and Khuri FR: The role of
the taxanes in the treatment of older patients with advanced stage
non-small cell lung cancer. Oncologist. 14:412–424. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Pan B, Chen D, Huang J, Wang R, Feng B,
Song H and Chen L: HMGB1-mediated autophagy promotes docetaxel
resistance in human lung adenocarcinoma. Mol Cancer. 13:1652014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang R, Huang J, Feng B, De W and Chen L:
Identification of ING4 (inhibitor of growth 4) as a modulator of
docetaxel sensitivity in human lung adenocarcinoma. Mol Med.
18:874–886. 2012.PubMed/NCBI
|
|
47
|
Miller VA and Kris MG: Docetaxel
(Taxotere) as a single agent and in combination chemotherapy for
the treatment of patients with advanced non-small cell lung cancer.
Semin Oncol. 27(Suppl 3): 3–10. 2000.PubMed/NCBI
|
|
48
|
Ku JL, Yoon KA, Kim IJ, Kim WH, Jang JY,
Suh KS, Kim SW, Park YH, Hwang JH, Yoon YB, et al: Establishment
and characterisation of six human biliary tract cancer cell lines.
Br J Cancer. 87:187–193. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Burdall SE, Hanby AM, Lansdown MR and
Speirs V: Breast cancer cell lines: Friend or foe? Breast Cancer
Res. 5:89–95. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
50
|
Osborne CK, Hobbs K and Trent JM:
Biological differences among MCF-7 human breast cancer cell lines
from different laboratories. Breast Cancer Res Treat. 9:111–121.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Gill DJ, Tham KM, Chia J, Wang SC,
Steentoft C, Clausen H, Bard-Chapeau EA and Bard FA: Initiation of
GalNAc-type O-glycosylation in the endoplasmic reticulum promotes
cancer cell invasiveness. Proc Natl Acad Sci USA. 110:E3152–E3161.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hua D, Shen L, Xu L, Jiang Z, Zhou Y, Yue
A, Zou S, Cheng Z and Wu S: Polypeptide
N-acetylgalactosaminyltransferase 2 regulates cellular
metastasis-associated behavior in gastric cancer. Int J Mol Med.
30:1267–1274. 2012.PubMed/NCBI
|
|
53
|
Wu YM, Liu CH, Hu RH, Huang MJ, Lee JJ,
Chen CH, Huang J, Lai HS, Lee PH, Hsu WM, et al: Mucin
glycosylating enzyme GALNT2 regulates the malignant character of
hepatocellular carcinoma by modifying the EGF receptor. Cancer Res.
71:7270–7279. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhu LF, Hu Y, Yang CC, Xu XH, Ning TY,
Wang ZL, Ye JH and Liu LK: Snail overexpression induces an
epithelial to mesenchymal transition and cancer stem cell-like
properties in SCC9 cells. Lab Invest. 92:744–752. 2012. View Article : Google Scholar : PubMed/NCBI
|
